首页> 外文OA文献 >The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity

【2h】

The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity

机译：慢性淋巴细胞白血病的结果，与种系具有97％IGHV基因同一性的患者与<97％同一性的病例不同，与具有98％同一性的病例相似

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Davis, Zadie; Forconi, Francesco; Parker, Anton; Gardiner, Anne; Thomas, Peter; Catovsky, Daniel; Rose-Zerilli, Matthew; Strefford, Jonathan C; Oscier, David;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with < 97% identity and similar to those with 98% identity [J] . Davis Zadie, Forconi Francesco, Parker Anton, British Journal of Haematology . 2016,第1期

机译：与种系具有IGHV基因同源性为97％的慢性淋巴细胞性白血病患者的结局不同于具有<97％同源性且与具有98％相同性的患者相似
2. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia [J] . Ke Shi, Qian Sun, Chun Qiao, Cancer Medicine . 2020,第3期

机译：98％Ighv基因身份是二分抑制中国慢性淋巴细胞白血病患者预后的最佳截止值
3. 98% IGHV Gene Identity Is Still the Optimal Cutoff to Predict the Prognosis of Chronic Lymphocytic Leukemia Patients in China [J] . Xia Yi, Shi Ke, Sun Qian, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：98％Ighv基因身份仍然是预测中国慢性淋巴细胞白血病患者预后的最佳截止
4. Efficiency and Toxmcity of the Fludarabine and Cyclo- Phosphamide Combined Therapy in Relapsed/ Resistant Patients with B-cell Chronic Lymphocytic Leukaemia (CLL)-Polish Multicenter Study [C] . M. Kowal, A. Dmoszynska, D. Jawniak, European Haematology Association . 2002

机译：B-Cell慢性淋巴细胞白血病（CLL） - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
5. Differential gene expression in B cell chronic lymphocytic leukemia patients with different clinical outcomes. [D] . Joshi, Avadhut D. 2006

机译：具有不同临床结局的B细胞慢性淋巴细胞性白血病患者的差异基因表达。
6. 98 IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia [O] . Ke Shi, Qian Sun, Chun Qiao, 2020

机译：98％IGHV基因同一性是将中国慢性淋巴细胞性白血病患者的预后二分法的最佳标准
7. The outcome of Chronic lymphocytic leukaemia patients with 97 IGHV gene identity to germline is distinct from cases with <97 identity and similar to those with 98 identity. [O] . Davis Z., Forconi F., Parker A., 2016

机译：与种系具有97％IGHV基因同一性的慢性淋巴细胞白血病患者的结局与具有<97％同一性且与具有98％同一性的病例不同。

The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity

著录项

引文网络

相似文献

相关主题

期刊订阅